Revolutionizing Pharma R&D

Teo Therapeutics (therapeutics ex ovo) was founded in 2023 with the goal that pharma can forego much of the expense of unnecessary mouse studies by pushing animal studies earlier into the R&D early discovery phase.

We are a spin-out of a childhood cancer drug discovery lab, cc-tdi.org

We use  the shell-free quail xenograft assay – an assay that can be executed in a standard laboratory instead of a vivarium, without the regulatory need for IACUC oversight and as a simple hardware + bioware Kit.

a key feature:  tightly controlled drug dosing.

At Teo Therapeutics, we are committed to meeting the call of  new federal legislation that gives pharmaceutical companies the option to forgo research using higher-order mammalian animal models.